Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meropenem Dosage Strategy in Elderly LRTI Patients
NCT01944319Phase 4Completed
- Start
- Jul 2013
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of meropenem in lower respiratory tract infection (LRTI) (2 arms). Primary endpoint: Clinical Success Rate. Started Jul 2013; status: completed.
02
Drugs
meropenem
03
Conditions
lower respiratory tract infection (LRTI)
Beyond the preview
Go deeper on NCT01944319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01944319.